Specifically, a cluster of differentiation 133 (CD133), which is commonly used as a molecular marker for cancer stem cells, has been shown to associate with Atg5, Beclin 1, and lysosomes, and CD133-positive cells exhibit increased levels of autophagy and the ability to adapt to the conditions of nutrient deprivation [34]. The gene discussed is PROM1; the disease is cancer.